Caverta 50 mg contains sildenafil citrate, a medication used primarily to treat erectile dysfunction. Its action is closely related to nitric oxide (NO) and cyclic guanosine monophosphate (cGMP), which are crucial in the physiological process of achieving and maintaining an erection.
When a man is sexually stimulated, nitric oxide is released in the corpus cavernosum (erectile tissue of the penis). This NO activates the enzyme guanylate cyclase, which increases the levels of cGMP. Elevated cGMP causes smooth muscle relaxation and vasodilation in the penile blood vessels, allowing increased blood flow and resulting in an erection.
CAVERTA 50 MG (sildenafil) works by inhibiting phosphodiesterase type 5 (PDE5), an enzyme that breaks down cGMP. By blocking PDE5, Caverta prolongs the action of cGMP, thereby enhancing and sustaining the erectile response to sexual stimulation.
In summary, Caverta 50 mg enhances the natural erectile process by supporting the nitric oxide–cGMP pathway. It does not directly cause an erection but facilitates it by maintaining higher cGMP levels in response to sexual arousal.
Add your comment